Advertisement

Index by author

October 01 1998; volume 47 issue 10

A

  1. Alberiche, M

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  2. Andersen, H U

    1. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

  3. Andersen, T

    1. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657

  4. Andersson, A

    1. Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586

B

  1. Barbetti, F

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  2. Bashan, N

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

  3. Behn, P S

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  4. Bernal-Mizrachi, E

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  5. Boden, G

    1. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609

  6. Boitard, C

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

  7. Bonadonna, R C

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  8. Bonora, E

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  9. Boppart, M D

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

  10. Buongiorno, A

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  11. Burk, S H

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

C

  1. Caillat-Zucman, S

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

  2. Carlsen, R C

    1. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637

  3. Carlsson, P O

    1. Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586

  4. Carpino, P A

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  5. Chayen, S

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  6. Chen, X

    1. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609

  7. Chester, M W

    1. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613

  8. Cronin, M J

    1. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637

D

  1. D'Adamo, M

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  2. Danforth, E

    1. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

  3. Daniels, M B

    1. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613

  4. Dobbins, R L

    1. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613

  5. Drijfhout, J W

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

  6. Dubois, D

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

  7. Dufresne, S D

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

  8. Dupont, S

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

  9. Duprat, L

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

E

  1. Echwald, S M

    1. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657

  2. Egger, G

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  3. Elias, K A

    1. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637

F

  1. Flatt, P R

    1. Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619

  2. Froguel, P

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

G

  1. Gant, T G

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  2. Geluk, A

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

  3. Giaccari, A

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  4. Gibson, L

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

  5. Giragossian, C

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  6. Glaser, B

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  7. Goodyear, L J

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

H

  1. Hemi, R

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

  2. Hirshman, M F

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

  3. Horton, E S

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

I

  1. Iqbal, N

    1. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609

J

  1. Jansson, L

    1. Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586

K

  1. Källskog, O

    1. Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586

  2. Kanety, H

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

  3. Karlsen, A E

    1. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

  4. Kelly, C M

    1. Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619

  5. Kiechl, S

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  6. Kwon, Y

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

L

  1. Larsen, C M

    1. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

  2. Lenzen, S

    1. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578

  3. Leonetti, F

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  4. Levy, C B

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  5. Liblau, R

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

  6. Lortz, S

    1. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578

M

  1. Mandrup-Poulsen, T

    1. Apoptosis and the pathogenesis of IDDM: a question of life and death.
      D Mauricio and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1537-1543. https://doi.org/10.2337/diabetes.47.10.1537
    2. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

  2. Maroccia, E

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  3. Martin, W H

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  4. Mauricio, D

    1. Apoptosis and the pathogenesis of IDDM: a question of life and death.
      D Mauricio and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1537-1543. https://doi.org/10.2337/diabetes.47.10.1537

  5. McDevitt, H O

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

  6. McGarry, J D

    1. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613

  7. McPherson, R K

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  8. Meyer, J

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  9. Mooney, M H

    1. Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619

  10. Muggeo, M

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  11. Munday, R

    1. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578

N

  1. Napoli, R

    1. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549

  2. Nielsen, K

    1. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

O

  1. O'Harte, F P

    1. Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619

  2. Oberhollenzer, F

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  3. Ottenhoff, T H

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

P

  1. Parker, J C

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  2. Pedersen, O

    1. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657

  3. Permutt, M A

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  4. Potashnik, R

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

R

  1. Ravussin, E

    1. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

  2. Roep, B O

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

  3. Rudich, A

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

S

  1. Sbraccia, P

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  2. Schloot, N C

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

  3. Singer, S M

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

  4. Snitker, S

    1. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

  5. Sørensen, T I

    1. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657

  6. Stein, D T

    1. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613

  7. Stewart, T A

    1. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637

  8. Sytwu, H K

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

T

  1. Tamburrano, G

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625

  2. Tao, T

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  3. Targher, G

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  4. Tataranni, P A

    1. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

  5. Tiedge, M

    1. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578

  6. Timsit, J

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

  7. Tirosh, A

    1. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562

  8. Tisch, R

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

  9. Treadway, J L

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  10. Tybjaerg-Hansen, A

    1. Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657

V

  1. van Meijgaarden, K E

    1. HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594

  2. VanVolkenburg, M A

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  3. Vestergaard, P

    1. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630

  4. Vionnet, N

    1. No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654

W

  1. Wadt, K A

    1. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602

  2. Wasson, J

    1. Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650

  3. Weyer, C

    1. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555

  4. Willeit, J

    1. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643

  5. Wilson, J E

    1. Distinguishing the type I and type II isozymes of hexokinase: the need for a reexamination of past practice.
      J E Wilson
      Diabetes 1998 Oct; 47 (10): 1544-1548. https://doi.org/10.2337/diabetes.47.10.1544

Y

  1. Yang, X D

    1. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570

Z

  1. Zorretta, D

    1. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
Back to top